The global Alzheimer's Non-Pharmacological Treatment Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Alzheimer's Non-Pharmacological Treatment Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

The North American market for Alzheimer's Non-Pharmacological Treatment Device is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Alzheimer's Non-Pharmacological Treatment Device is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Alzheimer's Non-Pharmacological Treatment Device include Magstim, NeuroConn, Abbott, Boston Scientific, Neuropace, Aleva Neurotherapeutics, Laborie, Electrocore, Medtronic, Interaxon, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Alzheimer's Non-Pharmacological Treatment Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Alzheimer's Non-Pharmacological Treatment Device. The Alzheimer's Non-Pharmacological Treatment Device market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Alzheimer's Non-Pharmacological Treatment Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Alzheimer's Non-Pharmacological Treatment Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Alzheimer's Non-Pharmacological Treatment Device Market Report

Report Metric	Details
Report Name	Alzheimer's Non-Pharmacological Treatment Device Market
Segment by Type	Brain Stimulation Device Optical and Acoustic Stimulation Device Others
by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Magstim, NeuroConn, Abbott, Boston Scientific, Neuropace, Aleva Neurotherapeutics, Laborie, Electrocore, Medtronic, Interaxon, Fisher Wallace, Dreem, SceneRay, Pins Medical, Spectris
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Alzheimer's Non-Pharmacological Treatment Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Alzheimer's Non-Pharmacological Treatment Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Alzheimer's Non-Pharmacological Treatment Device Market report?

Ans: The main players in the Alzheimer's Non-Pharmacological Treatment Device Market are Magstim, NeuroConn, Abbott, Boston Scientific, Neuropace, Aleva Neurotherapeutics, Laborie, Electrocore, Medtronic, Interaxon, Fisher Wallace, Dreem, SceneRay, Pins Medical, Spectris

What are the Application segmentation covered in the Alzheimer's Non-Pharmacological Treatment Device Market report?

Ans: The Applications covered in the Alzheimer's Non-Pharmacological Treatment Device Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Alzheimer's Non-Pharmacological Treatment Device Market report?

Ans: The Types covered in the Alzheimer's Non-Pharmacological Treatment Device Market report are Brain Stimulation Device, Optical and Acoustic Stimulation Device, Others

1 Alzheimer's Non-Pharmacological Treatment Device Market Overview

1.1 Product Definition

1.2 Alzheimer's Non-Pharmacological Treatment Device by Type

1.2.1 Global Alzheimer's Non-Pharmacological Treatment Device Market Value by Type: 2025 vs 2032

1.2.2 Brain Stimulation Device

1.2.3 Optical and Acoustic Stimulation Device

1.2.4 Others

1.3 Alzheimer's Non-Pharmacological Treatment Device by Application

1.3.1 Global Alzheimer's Non-Pharmacological Treatment Device Market Value by Application: 2025 vs 2032

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Alzheimer's Non-Pharmacological Treatment Device Market Size Estimates and Forecasts

1.4.1 Global Alzheimer's Non-Pharmacological Treatment Device Revenue 2021–2032

1.4.2 Global Alzheimer's Non-Pharmacological Treatment Device Sales 2021–2032

1.4.3 Global Alzheimer's Non-Pharmacological Treatment Device Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Alzheimer's Non-Pharmacological Treatment Device Market Competition by Manufacturers

2.1 Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Manufacturers (2021–2026)

2.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Alzheimer's Non-Pharmacological Treatment Device Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Alzheimer's Non-Pharmacological Treatment Device, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Alzheimer's Non-Pharmacological Treatment Device, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Alzheimer's Non-Pharmacological Treatment Device, Product Types and Applications

2.7 Global Key Manufacturers of Alzheimer's Non-Pharmacological Treatment Device, Date of Entry into the Industry

2.8 Global Alzheimer's Non-Pharmacological Treatment Device Market Competitive Situation and Trends

2.8.1 Global Alzheimer's Non-Pharmacological Treatment Device Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Alzheimer's Non-Pharmacological Treatment Device Players Market Share by Revenue

2.8.3 Global Alzheimer's Non-Pharmacological Treatment Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Alzheimer's Non-Pharmacological Treatment Device Market Scenario by Region

3.1 Global Alzheimer's Non-Pharmacological Treatment Device Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Alzheimer's Non-Pharmacological Treatment Device Sales by Region: 2021–2032

3.2.1 Global Alzheimer's Non-Pharmacological Treatment Device Sales by Region: 2021–2026

3.2.2 Global Alzheimer's Non-Pharmacological Treatment Device Sales by Region: 2027–2032

3.3 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Region: 2021–2032

3.3.1 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Region: 2021–2026

3.3.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Region: 2027–2032

3.4 North America Alzheimer's Non-Pharmacological Treatment Device Market Facts & Figures by Country

3.4.1 North America Alzheimer's Non-Pharmacological Treatment Device Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Alzheimer's Non-Pharmacological Treatment Device Sales by Country (2021–2032)

3.4.3 North America Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Alzheimer's Non-Pharmacological Treatment Device Market Facts & Figures by Country

3.5.1 Europe Alzheimer's Non-Pharmacological Treatment Device Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Alzheimer's Non-Pharmacological Treatment Device Sales by Country (2021–2032)

3.5.3 Europe Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Market Facts & Figures by Region

3.6.1 Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Sales by Region (2021–2032)

3.6.3 Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Alzheimer's Non-Pharmacological Treatment Device Market Facts & Figures by Country

3.7.1 Latin America Alzheimer's Non-Pharmacological Treatment Device Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Alzheimer's Non-Pharmacological Treatment Device Sales by Country (2021–2032)

3.7.3 Latin America Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Sales by Country (2021–2032)

3.8.3 Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2021–2032)

4.1.1 Global Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2021–2026)

4.1.2 Global Alzheimer's Non-Pharmacological Treatment Device Sales by Type (2027–2032)

4.1.3 Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Type (2021–2032)

4.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Type (2021–2032)

4.2.1 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Type (2021–2026)

4.2.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Type (2027–2032)

4.2.3 Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Type (2021–2032)

4.3 Global Alzheimer's Non-Pharmacological Treatment Device Price by Type (2021–2032)

5 Segment by Application

5.1 Global Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2021–2032)

5.1.1 Global Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2021–2026)

5.1.2 Global Alzheimer's Non-Pharmacological Treatment Device Sales by Application (2027–2032)

5.1.3 Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Application (2021–2032)

5.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Application (2021–2032)

5.2.1 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Application (2021–2026)

5.2.2 Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Application (2027–2032)

5.2.3 Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Application (2021–2032)

5.3 Global Alzheimer's Non-Pharmacological Treatment Device Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Magstim

6.1.1 Magstim Company Information

6.1.2 Magstim Description and Business Overview

6.1.3 Magstim Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Magstim Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.1.5 Magstim Recent Developments/Updates

6.2 NeuroConn

6.2.1 NeuroConn Company Information

6.2.2 NeuroConn Description and Business Overview

6.2.3 NeuroConn Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 NeuroConn Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.2.5 NeuroConn Recent Developments/Updates

6.3 Abbott

6.3.1 Abbott Company Information

6.3.2 Abbott Description and Business Overview

6.3.3 Abbott Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Abbott Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.3.5 Abbott Recent Developments/Updates

6.4 Boston Scientific

6.4.1 Boston Scientific Company Information

6.4.2 Boston Scientific Description and Business Overview

6.4.3 Boston Scientific Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Boston Scientific Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.4.5 Boston Scientific Recent Developments/Updates

6.5 Neuropace

6.5.1 Neuropace Company Information

6.5.2 Neuropace Description and Business Overview

6.5.3 Neuropace Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Neuropace Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.5.5 Neuropace Recent Developments/Updates

6.6 Aleva Neurotherapeutics

6.6.1 Aleva Neurotherapeutics Company Information

6.6.2 Aleva Neurotherapeutics Description and Business Overview

6.6.3 Aleva Neurotherapeutics Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Aleva Neurotherapeutics Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.6.5 Aleva Neurotherapeutics Recent Developments/Updates

6.7 Laborie

6.7.1 Laborie Company Information

6.7.2 Laborie Description and Business Overview

6.7.3 Laborie Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Laborie Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.7.5 Laborie Recent Developments/Updates

6.8 Electrocore

6.8.1 Electrocore Company Information

6.8.2 Electrocore Description and Business Overview

6.8.3 Electrocore Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Electrocore Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.8.5 Electrocore Recent Developments/Updates

6.9 Medtronic

6.9.1 Medtronic Company Information

6.9.2 Medtronic Description and Business Overview

6.9.3 Medtronic Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Medtronic Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.9.5 Medtronic Recent Developments/Updates

6.10 Interaxon

6.10.1 Interaxon Company Information

6.10.2 Interaxon Description and Business Overview

6.10.3 Interaxon Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Interaxon Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.10.5 Interaxon Recent Developments/Updates

6.11 Fisher Wallace

6.11.1 Fisher Wallace Company Information

6.11.2 Fisher Wallace Description and Business Overview

6.11.3 Fisher Wallace Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Fisher Wallace Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.11.5 Fisher Wallace Recent Developments/Updates

6.12 Dreem

6.12.1 Dreem Company Information

6.12.2 Dreem Description and Business Overview

6.12.3 Dreem Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Dreem Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.12.5 Dreem Recent Developments/Updates

6.13 SceneRay

6.13.1 SceneRay Company Information

6.13.2 SceneRay Description and Business Overview

6.13.3 SceneRay Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 SceneRay Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.13.5 SceneRay Recent Developments/Updates

6.14 Pins Medical

6.14.1 Pins Medical Company Information

6.14.2 Pins Medical Description and Business Overview

6.14.3 Pins Medical Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Pins Medical Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.14.5 Pins Medical Recent Developments/Updates

6.15 Spectris

6.15.1 Spectris Company Information

6.15.2 Spectris Description and Business Overview

6.15.3 Spectris Alzheimer's Non-Pharmacological Treatment Device Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Spectris Alzheimer's Non-Pharmacological Treatment Device Product Portfolio

6.15.5 Spectris Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Alzheimer's Non-Pharmacological Treatment Device Industry Chain Analysis

7.2 Alzheimer's Non-Pharmacological Treatment Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Alzheimer's Non-Pharmacological Treatment Device Production Mode & Process Analysis

7.4 Alzheimer's Non-Pharmacological Treatment Device Sales and Marketing

7.4.1 Alzheimer's Non-Pharmacological Treatment Device Sales Channels

7.4.2 Alzheimer's Non-Pharmacological Treatment Device Distributors

7.5 Alzheimer's Non-Pharmacological Treatment Device Customer Analysis

8 Alzheimer's Non-Pharmacological Treatment Device Market Dynamics

8.1 Alzheimer's Non-Pharmacological Treatment Device Industry Trends

8.2 Alzheimer's Non-Pharmacological Treatment Device Market Drivers

8.3 Alzheimer's Non-Pharmacological Treatment Device Market Challenges

8.4 Alzheimer's Non-Pharmacological Treatment Device Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Magstim

neuroConn

Abbott

Aleva Neurotherapeutics

List of Tables

Table 1. Global Alzheimer's Non-Pharmacological Treatment Device Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Alzheimer's Non-Pharmacological Treatment Device Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Alzheimer's Non-Pharmacological Treatment Device Market Competitive Situation by Manufacturers in 2025

Table 4. Global Alzheimer's Non-Pharmacological Treatment Device Sales (Units) of Key Manufacturers (2021–2026)

Table 5. Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Alzheimer's Non-Pharmacological Treatment Device Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Alzheimer's Non-Pharmacological Treatment Device Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Alzheimer's Non-Pharmacological Treatment Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Alzheimer's Non-Pharmacological Treatment Device, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Alzheimer's Non-Pharmacological Treatment Device, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Alzheimer's Non-Pharmacological Treatment Device, Product Types and Applications

Table 12. Global Key Manufacturers of Alzheimer's Non-Pharmacological Treatment Device, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Alzheimer's Non-Pharmacological Treatment Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Alzheimer's Non-Pharmacological Treatment Device Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Alzheimer's Non-Pharmacological Treatment Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Alzheimer's Non-Pharmacological Treatment Device Sales by Region (Units), 2021–2026

Table 18. Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Region (2021–2026)

Table 19. Global Alzheimer's Non-Pharmacological Treatment Device Sales by Region (Units), 2027–2032

Table 20. Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Region (2027–2032)

Table 21. Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Region (US$ Million), 2021–2026

Table 22. Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Region (2021–2026)

Table 23. Global Alzheimer's Non-Pharmacological Treatment Device Revenue by Region (US$ Million), 2027–2032

Table 24. Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Region (2027–2032)

Table 25. North America Alzheimer's Non-Pharmacological Treatment Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Alzheimer's Non-Pharmacological Treatment Device Sales by Country (Units), 2021–2026

Table 27. North America Alzheimer's Non-Pharmacological Treatment Device Sales by Country (Units), 2027–2032

Table 28. North America Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (US$ Million), 2021–2026

Table 29. North America Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Alzheimer's Non-Pharmacological Treatment Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Alzheimer's Non-Pharmacological Treatment Device Sales by Country (Units), 2021–2026

Table 32. Europe Alzheimer's Non-Pharmacological Treatment Device Sales by Country (Units), 2027–2032

Table 33. Europe Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Sales by Region (Units), 2021–2026

Table 37. Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Sales by Region (Units), 2027–2032

Table 38. Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Alzheimer's Non-Pharmacological Treatment Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Alzheimer's Non-Pharmacological Treatment Device Sales by Country (Units), 2021–2026

Table 42. Latin America Alzheimer's Non-Pharmacological Treatment Device Sales by Country (Units), 2027–2032

Table 43. Latin America Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Sales by Country (Units), 2021–2026

Table 47. Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Sales by Country (Units), 2027–2032

Table 48. Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Revenue by Country (US$ Million), 2027–2032

Table 50. Global Alzheimer's Non-Pharmacological Treatment Device Sales (Units) by Type (2021–2026)

Table 51. Global Alzheimer's Non-Pharmacological Treatment Device Sales (Units) by Type (2027–2032)

Table 52. Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Type (2021–2026)

Table 53. Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Type (2027–2032)

Table 54. Global Alzheimer's Non-Pharmacological Treatment Device Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Alzheimer's Non-Pharmacological Treatment Device Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Type (2021–2026)

Table 57. Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Type (2027–2032)

Table 58. Global Alzheimer's Non-Pharmacological Treatment Device Price (US$/Unit) by Type (2021–2026)

Table 59. Global Alzheimer's Non-Pharmacological Treatment Device Price (US$/Unit) by Type (2027–2032)

Table 60. Global Alzheimer's Non-Pharmacological Treatment Device Sales (Units) by Application (2021–2026)

Table 61. Global Alzheimer's Non-Pharmacological Treatment Device Sales (Units) by Application (2027–2032)

Table 62. Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Application (2021–2026)

Table 63. Global Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Application (2027–2032)

Table 64. Global Alzheimer's Non-Pharmacological Treatment Device Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Alzheimer's Non-Pharmacological Treatment Device Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Application (2021–2026)

Table 67. Global Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Application (2027–2032)

Table 68. Global Alzheimer's Non-Pharmacological Treatment Device Price (US$/Unit) by Application (2021–2026)

Table 69. Global Alzheimer's Non-Pharmacological Treatment Device Price (US$/Unit) by Application (2027–2032)

Table 70. Magstim Company Information

Table 71. Magstim Description and Business Overview

Table 72. Magstim Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Magstim Alzheimer's Non-Pharmacological Treatment Device Product

Table 74. Magstim Recent Developments/Updates

Table 75. NeuroConn Company Information

Table 76. NeuroConn Description and Business Overview

Table 77. NeuroConn Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. NeuroConn Alzheimer's Non-Pharmacological Treatment Device Product

Table 79. NeuroConn Recent Developments/Updates

Table 80. Abbott Company Information

Table 81. Abbott Description and Business Overview

Table 82. Abbott Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Abbott Alzheimer's Non-Pharmacological Treatment Device Product

Table 84. Abbott Recent Developments/Updates

Table 85. Boston Scientific Company Information

Table 86. Boston Scientific Description and Business Overview

Table 87. Boston Scientific Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Boston Scientific Alzheimer's Non-Pharmacological Treatment Device Product

Table 89. Boston Scientific Recent Developments/Updates

Table 90. Neuropace Company Information

Table 91. Neuropace Description and Business Overview

Table 92. Neuropace Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Neuropace Alzheimer's Non-Pharmacological Treatment Device Product

Table 94. Neuropace Recent Developments/Updates

Table 95. Aleva Neurotherapeutics Company Information

Table 96. Aleva Neurotherapeutics Description and Business Overview

Table 97. Aleva Neurotherapeutics Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. Aleva Neurotherapeutics Alzheimer's Non-Pharmacological Treatment Device Product

Table 99. Aleva Neurotherapeutics Recent Developments/Updates

Table 100. Laborie Company Information

Table 101. Laborie Description and Business Overview

Table 102. Laborie Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. Laborie Alzheimer's Non-Pharmacological Treatment Device Product

Table 104. Laborie Recent Developments/Updates

Table 105. Electrocore Company Information

Table 106. Electrocore Description and Business Overview

Table 107. Electrocore Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. Electrocore Alzheimer's Non-Pharmacological Treatment Device Product

Table 109. Electrocore Recent Developments/Updates

Table 110. Medtronic Company Information

Table 111. Medtronic Description and Business Overview

Table 112. Medtronic Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. Medtronic Alzheimer's Non-Pharmacological Treatment Device Product

Table 114. Medtronic Recent Developments/Updates

Table 115. Interaxon Company Information

Table 116. Interaxon Description and Business Overview

Table 117. Interaxon Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 118. Interaxon Alzheimer's Non-Pharmacological Treatment Device Product

Table 119. Interaxon Recent Developments/Updates

Table 120. Fisher Wallace Company Information

Table 121. Fisher Wallace Description and Business Overview

Table 122. Fisher Wallace Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 123. Fisher Wallace Alzheimer's Non-Pharmacological Treatment Device Product

Table 124. Fisher Wallace Recent Developments/Updates

Table 125. Dreem Company Information

Table 126. Dreem Description and Business Overview

Table 127. Dreem Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 128. Dreem Alzheimer's Non-Pharmacological Treatment Device Product

Table 129. Dreem Recent Developments/Updates

Table 130. SceneRay Company Information

Table 131. SceneRay Description and Business Overview

Table 132. SceneRay Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 133. SceneRay Alzheimer's Non-Pharmacological Treatment Device Product

Table 134. SceneRay Recent Developments/Updates

Table 135. Pins Medical Company Information

Table 136. Pins Medical Description and Business Overview

Table 137. Pins Medical Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 138. Pins Medical Alzheimer's Non-Pharmacological Treatment Device Product

Table 139. Pins Medical Recent Developments/Updates

Table 140. Spectris Company Information

Table 141. Spectris Description and Business Overview

Table 142. Spectris Alzheimer's Non-Pharmacological Treatment Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 143. Spectris Alzheimer's Non-Pharmacological Treatment Device Product

Table 144. Spectris Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Alzheimer's Non-Pharmacological Treatment Device Distributors List

Table 148. Alzheimer's Non-Pharmacological Treatment Device Customers List

Table 149. Alzheimer's Non-Pharmacological Treatment Device Market Trends

Table 150. Alzheimer's Non-Pharmacological Treatment Device Market Drivers

Table 151. Alzheimer's Non-Pharmacological Treatment Device Market Challenges

Table 152. Alzheimer's Non-Pharmacological Treatment Device Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Alzheimer's Non-Pharmacological Treatment Device

Figure 2. Global Alzheimer's Non-Pharmacological Treatment Device Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Alzheimer's Non-Pharmacological Treatment Device Market Share by Type: 2025 & 2032

Figure 4. Brain Stimulation Device Product Picture

Figure 5. Optical and Acoustic Stimulation Device Product Picture

Figure 6. Others Product Picture

Figure 7. Global Alzheimer's Non-Pharmacological Treatment Device Market Value by Application (US$ Million), 2021–2032

Figure 8. Global Alzheimer's Non-Pharmacological Treatment Device Market Share by Application: 2025 & 2032

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Others

Figure 12. Global Alzheimer's Non-Pharmacological Treatment Device Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Alzheimer's Non-Pharmacological Treatment Device Market Size (US$ Million), 2021–2032

Figure 14. Global Alzheimer's Non-Pharmacological Treatment Device Sales (Units), 2021–2032

Figure 15. Global Alzheimer's Non-Pharmacological Treatment Device Average Price (US$/Unit), 2021–2032

Figure 16. Alzheimer's Non-Pharmacological Treatment Device Report Years Considered

Figure 17. Alzheimer's Non-Pharmacological Treatment Device Sales Share by Manufacturers in 2025

Figure 18. Global Alzheimer's Non-Pharmacological Treatment Device Revenue Share by Manufacturers in 2025

Figure 19. Top 5 and Top 10 Global Alzheimer's Non-Pharmacological Treatment Device Players: Market Share by Revenue in Alzheimer's Non-Pharmacological Treatment Device in 2025

Figure 20. Alzheimer's Non-Pharmacological Treatment Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 21. Global Alzheimer's Non-Pharmacological Treatment Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 22. North America Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Country (2021–2032)

Figure 23. North America Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Country (2021–2032)

Figure 24. United States Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Canada Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Europe Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Country (2021–2032)

Figure 27. Europe Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Country (2021–2032)

Figure 28. Germany Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. France Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. U.K. Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Italy Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Russia Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Region (2021–2032)

Figure 34. Asia Pacific Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Region (2021–2032)

Figure 35. China Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Japan Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. South Korea Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. India Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Australia Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. China Taiwan Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Southeast Asia Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Latin America Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Country (2021–2032)

Figure 43. Latin America Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Country (2021–2032)

Figure 44. Mexico Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Brazil Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Argentina Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Colombia Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Sales Market Share by Country (2021–2032)

Figure 49. Middle East and Africa Alzheimer's Non-Pharmacological Treatment Device Revenue Market Share by Country (2021–2032)

Figure 50. Turkey Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Saudi Arabia Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. UAE Alzheimer's Non-Pharmacological Treatment Device Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Global Sales Market Share of Alzheimer's Non-Pharmacological Treatment Device by Type (2021–2032)

Figure 54. Global Revenue Market Share of Alzheimer's Non-Pharmacological Treatment Device by Type (2021–2032)

Figure 55. Global Alzheimer's Non-Pharmacological Treatment Device Price (US$/Unit) by Type (2021–2032)

Figure 56. Global Sales Market Share of Alzheimer's Non-Pharmacological Treatment Device by Application (2021–2032)

Figure 57. Global Revenue Market Share of Alzheimer's Non-Pharmacological Treatment Device by Application (2021–2032)

Figure 58. Global Alzheimer's Non-Pharmacological Treatment Device Price (US$/Unit) by Application (2021–2032)

Figure 59. Alzheimer's Non-Pharmacological Treatment Device Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions